K
Kumar Dharmarajan
Researcher at Yale University
Publications - 106
Citations - 7667
Kumar Dharmarajan is an academic researcher from Yale University. The author has contributed to research in topics: Heart failure & Myocardial infarction. The author has an hindex of 31, co-authored 103 publications receiving 6560 citations. Previous affiliations of Kumar Dharmarajan include Peking Union Medical College & Harvard University.
Papers
More filters
Journal ArticleDOI
Pathway from Delirium to Death: Potential In-Hospital Mediators of Excess Mortality.
TL;DR: This work aims to determine the relationship of incident delirium during hospitalization with 90‐day mortality and identify potential in‐hospital mediators through whichDelirium increases 90-day mortality.
Journal ArticleDOI
Sex Differences in 1-Year All-Cause Rehospitalization in Patients After Acute Myocardial Infarction: A Prospective Observational Study.
Rachel P. Dreyer,Kumar Dharmarajan,Kevin F. Kennedy,Philip G. Jones,Viola Vaccarino,Karthik Murugiah,Sudhakar V. Nuti,Kim G. Smolderen,Donna M Buchanan,John A. Spertus,Harlan M. Krumholz +10 more
TL;DR: In this article, women are at higher risk of rehospitalization in the first month after discharge for acute myocardial infarction (AMI), however, it is unknown whether this risk extend.
Journal ArticleDOI
Patient-Provider Communication and Health Outcomes Among Individuals With Atherosclerotic Cardiovascular Disease in the United States: Medical Expenditure Panel Survey 2010 to 2013.
Victor Okunrintemi,Erica S. Spatz,Paul Di Capua,Joseph A Salami,Javier Valero-Elizondo,Haider J. Warraich,Salim S. Virani,Salim S. Virani,Michael J. Blaha,Ron Blankstein,Adeel A. Butt,William B. Borden,Kumar Dharmarajan,Henry Ting,Harlan M. Krumholz,Khurram Nasir +15 more
TL;DR: A strong relationship is revealed between PPC and patient-reported outcomes, utilization of evidence-based therapies, healthcare resource utilization, and expenditures among those with established atherosclerotic cardiovascular disease.
Journal ArticleDOI
Assessment of Instruments for Measurement of Delirium Severity: A Systematic Review.
Richard N. Jones,Sevdenur Cizginer,Laura L. Pavlech,Asha Albuquerque,Lori A. Daiello,Kumar Dharmarajan,Lauren J. Gleason,Benjamin K. I. Helfand,Benjamin K. I. Helfand,Lauren Massimo,Esther S. Oh,Olivia I. Okereke,Olivia I. Okereke,Olivia I. Okereke,Patricia Tabloski,Laura A. Rabin,Jirong Yue,Edward R. Marcantonio,Edward R. Marcantonio,Tamara G. Fong,Tamara G. Fong,Tammy T. Hshieh,Tammy T. Hshieh,Eran D. Metzger,Eran D. Metzger,Kristen Erickson,Eva M. Schmitt,Sharon K. Inouye,Sharon K. Inouye +28 more
TL;DR: 6 instruments identified may enable accurate measurement of delirium severity to improve clinical care for patients with this condition and may stimulate increased usage and head-to-head comparison of these instruments.
Journal ArticleDOI
Dominance of Furosemide for Loop Diuretic Therapy in Heart Failure: Time to Revisit the Alternatives?
Behnood Bikdeli,Kelly M. Strait,Kumar Dharmarajan,Chohreh Partovian,Steven G. Coca,Nancy Kim,Shu-Xia Li,Jeffrey M. Testani,Usman Khan,Harlan M. Krumholz +9 more
TL;DR: To the Editor: Diuretics are a mainstay of treatment in both chronic and acute decompensated heart failure (HF) and studies during the 1990s and early 2000s show that roughly 90% of HF patients receive at least 1 class of diuretics.